Checked.be
Active
BE 0422.792.415Public limited company
APOTHEEK PEETERS
Voort 4 ·3272 Scherpenheuvel-Zichem, Belgium· 44 yrs active
Sector: Retail sale of pharmaceutical products
(47730)
Conclusion
APOTHEEK PEETERS has been active since 1982 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €366k and a net result of €318k. Equity remains stable across the filed fiscal years (±0% per year). Its solvency ranks better than 39% of 480 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Based on the State Gazette, CBE and 3 annual accounts.
Key figures
| Equity | €366k |
| Net result | €318k |
| Staff (FTE) | 2.6 |
| Better than sector | 39% |
Financial profile
69
/ 100
Strong profile, led by profitability.
All 5 axes are computed from data Checked has read.
Health
71
Profitability
100
Solvency
22
Growth
52
Stability
100
Bankruptcy probability (12 mo)
Risk Assessment
0 / 100
Low riskTrust signals
Long-established
Founded in 1982, 44 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Checked score
71
/ 100
Healthy
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.
Financial overview
Annual accounts filed on 03-06-2026 with the NBB · fiscal year 2025 · abbreviated schema
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
stable
Equity: stable across 3 fiscal years (±0%/year).
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Sector comparison
Fiscal year 2025 · NACE 47, Retail trade · compared within the same schema type (abbreviated schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 15.1% | 21.2% | |
| Net result | €318k | €32k | |
| Equity | €366k | €163k | |
| Gross operating margin | €677k | €281k | |
| Staff costs | €190k | €211k |
€485k
+6.5%
23-25
€318k
+2.7%
23-25
€401k
+2.2%
23-25
€2.43M
+9.4%
23-25
€366k
0.0%
23-25
€98k
+50.9%
23-25
3
+18.2%
23-25
€190k
+14.9%
23-25
€90k
+26.4%
23-25
€258k
+28.9%
23-25
€2.06M
+11.3%
23-25
€1.68M
+17.5%
23-25
€376k
-10.0%
23-25
1.06
+1.2%
23-25
0.87
+5.1%
23-25
15.1%
-8.6%
23-25
5.63
+11.3%
23-25
86.7%
+2.6%
23-25
13.1%
-6.2%
23-25
42.73
-2.7%
23-25
Figures by fiscal year and ratios
| Fiscal year | 2025 |
|---|---|
| Deposit | abbreviated schema |
| Revenue | - |
| EBITDA | €485k |
| Net profit | €318k |
| Cash flow | €401k |
| Staff costs | €190k |
| Income taxes | €90k |
| Dividends | €258k |
| Total assets | €2.43M |
| Equity | €366k |
| Debt | €2.06M |
| of which ≤ 1y | €1.68M |
| of which > 1y | €376k |
| Working capital | €98k |
| Employees (FTE) | 2.6 |
Ratios (computed)
| 2025 | |
|---|---|
| Current ratio | 1.06 |
| Quick ratio | 0.87 |
| Working capital ratio | 4.0% |
| Solvency | 15.1% |
| Debt / equity | 5.63 |
| Long-term debt ratio | 1.03 |
| Interest coverage | 42.73 |
| Gross margin | - |
| Net margin | - |
| ROA | 13.1% |
| ROE | 86.7% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
This table shows the latest fiscal year. 2 prior years, with figures and ratios, belong to a paid plan.
See plans →
Balance-sheet composition 2025
Full annual accounts (26 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €2.43M |
| Fixed assets | 21/28 | €649k |
| Tangible fixed assets | 22/27 | €644k |
| Financial fixed assets | 28 | €5k |
| Current assets | 29/58 | €1.78M |
| Stocks & contracts in progress | 3 | €318k |
| Amounts receivable within one year | 40/41 | €214k |
| Investments | 50/53 | €0 |
| Cash & bank | 54/58 | €1.21M |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €2.43M |
| Equity | 10/15 | €366k |
| Contributions / capital | 10/11 | €81k |
| Reserves | 13 | €285k |
| Accumulated profits (losses) | 14 | €0 |
| Amounts payable | 17/49 | €2.06M |
| Amounts payable after one year | 17 | €376k |
| Amounts payable within one year | 42/48 | €1.68M |
| Trade debts payable within one year | 44 | €448k |
| Income statement | ||
| Gross operating margin | 9900 | €677k |
| Operating result | 9901 | €401k |
| Financial income | 75 | €17k |
| Financial charges | 65 | €11k |
| Result before taxes | 9903 | €407k |
| Income taxes | 67/77 | €90k |
| Net result for the period | 9904 | €318k |
| Result to be appropriated | 9905 | €318k |
Legal Structure
| NACE primary | Retail sale of pharmaceutical products(47730) |
| Legal form | Public limited company(014) |
| Incorporation | 15-06-1982 |
| Status | Active |
| Postal code | 3272 |
Establishment units
APOTHEEK PEETERS NV
since 19822.020.678.165
Real-estate footprint
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24105D0118/00N000 | Flanders | 4,911 m² | 1 · 330 m² | 12.0 m · 2 fl. |
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates
2026
03-06-2026 NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
25-07-2025 NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
27-08-2024 NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-08-2023 NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-08-2022 NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
20-08-2021 NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
20-08-2020 NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
28-06-2019 NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
14-08-2018 NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
23-08-2017 NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Belgian State Gazette reading coverage
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Credit advice
Company registry (CBE)
Activities
Retail sale of pharmaceutical products4773052310
Names & trade names
| Legal nameNL | APOTHEEK PEETERS |
Similar companies
Apotheek Weert
BE 0898.636.110 · Oud-Heverlee
Pharmacie SCANU - HAINE
BE 0449.123.757 · Quiévrain
APOTHEEK WAUTERS
BE 0892.363.376 · Tongeren-Borgloon
APOTHEEK PHARMAGO
BE 0476.498.048 · Nazareth-De Pinte
APOTHEEK DEMEER
BE 0446.367.670 · Leuven